Search the Newsreel

Morgan Stanley's Adam Jonas lays out how SpaceX can unlock a long-term bullish stock move

Morgan Stanley analyst Adam Jonas believes SpaceX can achieve a long-term bullish stock move, driven by the potential of its SpaceXAI division, particularly with products like Grok Bot. Jonas emphasizes that for SpaceXAI to be valued beyond a "neocloud," it needs to demonstrate its …

Stantec Backs Annual Guidance On Strong Demand

(RTTNews) - Stantec Inc. (STN, STN.TO), a Canadian engineering, architecture, and environmental services provider, has reaffirmed its annual guidance to reflect strong demand and favorable market conditions. For fiscal 2026, the company still expects adjusted income per share growth of 15% to 18%, with …

Polycab India: Morgan Stanley raises price target past Rs 10,000 mark; here's why

Hindustan Oil Exploration Company consolidated net profit declines 85.78% in the June 2026 quarter

(SMP) Volatility Zones as Tactical Triggers

The article analyzes Standard Motor Products Inc. (NYSE: SMP), identifying a neutral sentiment across all time horizons and a mid-channel oscillation pattern. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis highlights an …

StandardAero CEO Russell Ford sells $1,230 in stock By Investing.com

StandardAero CEO Russell Ford sold 41 shares of common stock for $1,230 on August 10, 2026, as part of a Rule 10b5-1 trading plan. Following the sale, he directly holds 14,342 shares and indirectly owns 295,532 shares through a Family LLC. The company's stock …

STANLEY BLACK DECKER AKTIE: AI-Analysen, Prognose & Kursziel

LifeStance Health Group (NASDAQ:LFST) Major Shareholder Tpg Gp A, Llc Sells 13,643,207 Shares

Major shareholder Tpg Gp A, Llc sold over 13.6 million shares of LifeStance Health Group (NASDAQ:LFST) for approximately $144.9 million, reducing their stake by 12.21%. This transaction follows LifeStance's strong quarterly performance, which saw an EPS beat and 26.1% year-over-year revenue growth, pushing the …

StandardAero CEO Russell Ford sells $1,230 in stock

StandardAero CEO Russell Ford sold 41 shares of common stock for $1,230 on August 10, 2026, under a pre-arranged trading plan. Despite the sale, he retains significant direct and indirect holdings in the company, which recently reported a 4.6% revenue increase and raised its …

Standard Chartered PLC (2888.HK) stock price, news, quote and history

Stantec (NYSE:STN) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Stantec (STN) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Stantec (STN) Surpasses Q2 Earnings Estimates

Stantec (STN) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Morgan Stanley's infrastructure partner Zerohash rebuffed in pitch to be U.S. trust bank

Zerohash, the crypto infrastructure provider for Morgan Stanley's E*Trade, had its initial application to become a U.S. trust bank returned by the Office of the Comptroller of the Currency (OCC) due to "material deficiencies." The company plans to re-file its application with a narrower …

Standard Nuclear plans its Q2 results webcast for Aug. 27

Standard Nuclear, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call

Morgan Stanley (SPHR) discloses 8.3% beneficial stake in Sphere Entertainment Co.

Morgan Stanley and its subsidiary Morgan Stanley Capital Services LLC have reported an 8.3% beneficial ownership in Sphere Entertainment Co. Class A Common Stock through an amended Schedule 13G filing. This includes 2,410,126 shares beneficially owned by Morgan Stanley and 2,252,618 shares by Morgan …

Standex International (SXI) awards 2,285 RSUs to senior executive

Standex International (SXI) has granted 2,285 Restricted Stock Units (RSUs) to Richard Colby Slaughter, CLO, VP, and Secretary, on August 10, 2026. These RSUs, tied to common stock, will vest in three equal installments on August 10, 2027, 2028, and 2029. Following this award, …

Standex International (SXI) officer Slaughter files initial Form 3 insider report

Richard Colby Slaughter, CLO, Vice President, and Secretary of Standex International Corp. (SXI), has filed an initial statement of beneficial ownership (Form 3). This filing establishes Slaughter as a reporting person but does not indicate any current equity holdings or transactions in company securities. …

Morgan Stanley (NXDT) drops below 5% ownership in NexPoint Diversified Real Estate Trust

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an amended passive investment disclosure (SCHEDULE 13G/A) indicating they have reduced their beneficial ownership in NexPoint Diversified Real Estate Trust (NXDT) to below 5%. Morgan Stanley now holds 4.3% of the outstanding …

Stantec (NYSE:STN) Releases FY 2026 Earnings Guidance

Stantec Q2 Adjusted Earnings Climbs 18%

Stantec (STN.TO) said Wednesday after trade that adjusted earnings jumped 18.4% to C$1.61 per share, from C$1.36 per share, in the prior year period.Analysts polled by FactSet had expected C$1.58 per share.Net revenue increased 11.5% year over year to C$1.8 billion, in line with …

Earnings Flash (STN) Stantec Posts Q2 Adjusted EPS CA$1.61, vs. FactSet Est of CA$1.57

Stantec Inc. (STN) announced its Q2 adjusted EPS of CA$1.61, surpassing FactSet's estimate of CA$1.57. This financial update indicates a positive performance for the company in the second quarter. The article also mentions other recent news concerning Stantec, including its Q2 adjusted earnings climbing …

Stantec: Q2 Earnings Snapshot

Stantec Inc. reported second-quarter net income of $108.6 million, or 95 cents per share. Adjusted earnings of $1.16 per share beat Wall Street estimates of $1.15 per share. However, the engineering firm's adjusted revenue of $1.29 billion missed Street forecasts of $1.3 billion.

Tactile Systems Technology (TCMD): Morgan Stanley trims stake to about 3.7%

Morgan Stanley and its affiliate, Morgan Stanley Capital Services LLC, have reduced their beneficial ownership in Tactile Systems Technology Inc. (TCMD). Morgan Stanley now holds 3.7% of TCMD common stock, while Morgan Stanley Capital Services LLC holds 3.5%, with both entities reporting that they …

LifeStance CTO Vukasin Paunovich sells $481,674 in stock

LifeStance Health Group's CTO, Vukasin Paunovich, sold 44,394 shares worth $481,674 on August 10, 2026. This sale occurred after the stock surged 147% over the past year, trading 13% higher than the sale price. The company recently reported strong Q2 2026 financial results, exceeding …

LifeStance Health Group (LFST) Stock Looks Strong On Returns Yet Stretched On Earnings

Morgan Stanley (PROK) filings show ProKidney stake at 4.7% and below 5% level

Morgan Stanley and its affiliate, Morgan Stanley Investment Management Inc., have reported their current beneficial ownership in ProKidney Corp. Class A common stock through a Schedule 13G/A amendment. Both entities now hold a 4.7% stake, individually owning approximately 9.65 million and 9.64 million shares …

Morgan Stanley, Parametric (EMD) disclose 8.7% holding in emerging markets debt fund

Morgan Stanley and Parametric Portfolio Associates LLC have reported a beneficial ownership of 8.7% in Western Asset Emerging Markets Debt Fund Inc., totaling 5,041,719 shares. This disclosure, made via an amended Schedule 13G, indicates shared voting and dispositive power over these shares, with 686,302 …

Morgan Stanley (USPH) cuts U S Physical Therapy stake to 3.9% of shares

Morgan Stanley has reduced its beneficial ownership in U.S. Physical Therapy, Inc. (USPH) to 3.9% of common stock, filing an amended ownership report (SCHEDULE 13G/A). This new stake, totaling 596,683 shares, is below the 5% reporting threshold, indicating Morgan Stanley is no longer a …

Morgan Stanley Maintains Brookfield Infrastructure Partners LP(BIP.US) With Buy Rating, Maintains Target Price $48

Morgan Stanley has reiterated its Buy rating for Brookfield Infrastructure Partners LP (BIP.US), alongside maintaining a target price of $48. This indicates the firm's continued positive outlook on the infrastructure company's stock.

Morgan Stanley’s Weaver Warns of Risks in AI-Compute Bottleneck

Morgan Stanley's Michelle Weaver warns that artificial intelligence growth is constrained by a persistent bottleneck in computing supply. She notes that demand for AI computing continues to outstrip available capacity and anticipates that power, political, and labor bottlenecks will limit supply for the next …

Spectacular new Morgan Stanley display lights up Times Square: ‘Broadway is a bit brighter’

Morgan Stanley has unveiled a spectacular new 21,000-square-foot digital display at its 1585 Broadway headquarters in Times Square. The installation, which features 31.5 million pixels and frequently showcases "CRYPTO" messages, replaces an older display from 2015. Times Square Alliance president Tom Harris noted that …

Affiliated Managers Group (AMG): Morgan Stanley, Atlanta Capital detail 5.5% and 4.7% stakes

Morgan Stanley and Atlanta Capital Management Company, LLC have filed an amended Schedule 13G detailing their stakes in Affiliated Managers Group, Inc. As of June 30, 2026, Morgan Stanley beneficially owns 5.5% of AMG's common stock, while Atlanta Capital reports a 4.7% stake and …

Morgan Stanley (ATR) discloses 3.23M AptarGroup shares in Schedule 13G/A

Morgan Stanley has filed an amended Schedule 13G/A, disclosing beneficial ownership of 3,232,550 shares of AptarGroup, Inc. common stock, which represents a 5.1% stake in the company as of June 30, 2026. The filing details shared voting power over 2,870,214 shares and shared dispositive …

Morgan Stanley (ABUS) units report near-9% Arbutus Biopharma stake in 13G/A filing

Morgan Stanley and Morgan Stanley Investment Management Inc. have disclosed significant beneficial ownership in Arbutus Biopharma Corp (ABUS) common shares through a Schedule 13G/A filing. As of June 30, 2026, Morgan Stanley reporting units beneficially own 8.8% of Arbutus Biopharma's common shares, while Morgan …

Stanley Black & Decker (SWK) investirá US$ 1 bilhão nos EUA até 2028